Investigating the role of a specific enzyme in cell repair and death regulation
The Biology of Peroxiredoxin 6
This study is looking at a special enzyme called Prdx6 that helps protect and repair cells, especially in serious conditions like lung injuries and brain diseases, to see how it can stop harmful cell death and possibly lead to new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10877141 on NIH RePORTER |
What this research studies
This research focuses on Peroxiredoxin 6 (Prdx6), an enzyme that plays a crucial role in repairing damaged cell membranes and regulating cell death. The study aims to understand how Prdx6 functions in various conditions, including acute lung injury and neurodegenerative diseases, by examining its activities related to antioxidant defense and lipid metabolism. Using advanced techniques, researchers will explore how Prdx6 can prevent a specific type of cell death known as ferroptosis, which is linked to several serious health issues. The findings could provide insights into potential therapeutic targets for these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from acute lung injury, neurodegenerative diseases, or type 2 diabetes.
Not a fit: Patients with conditions unrelated to oxidative stress or cell membrane repair may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for conditions like acute lung injury, neurodegenerative diseases, and type 2 diabetes by targeting the mechanisms of cell repair and death.
How similar studies have performed: Other research has shown promising results in understanding the role of similar enzymes in cell death regulation, suggesting that this approach could yield valuable insights.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Vazquez Medina, Jose P — University of California Berkeley
- Study coordinator: Vazquez Medina, Jose P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.